(PDF) Apatinib Monotherapy as a Second-Line Treatment for

Apatinib Monotherapy as a Second-Line Treatment for Patients With Advanced Biliary Tract Cancer: A Retrospective Single-Center Observational Study

doi 10.17303/jcrto.2019.7.205

Full Text

Abstract

Available in full text

Date

November 3, 2019

Authors

Unknown

Publisher

JScholar

Related search

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

Korean Journal of Internal Medicine

Internal Medicine

English

Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study

Gastroenterology

English

Endovascular Treatment for Acute Basilar Artery Occlusion: A Single Center Retrospective Observational Study

English

A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience.

Journal of Clinical Oncology

Cancer Research

English

A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience

Cancer Research and Treatment

Cancer Research

English

P1.12-01 a Single-Arm Multi-Center Phase II Study of Apatinib in Patients With ES-SCLC After Second/Third-Line Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial

Journal of the International Association of Providers of AIDS Care

Infectious Diseases

English

P109 Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients With Sensitive Relapsed SCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Association Between Early Nutritional Risk and Overall Survival in Patients With Advanced Pancreatic Cancer: A Single-Center Retrospective Study

Clinical Nutrition ESPEN

English